Parker Richard T, Vahdani Kaveh, Rose Geoffrey E
Orbital Service, Moorfields Eye Hospital, London, United Kingdom.
Faculty of Medicine and Health, Save Sight Institute, University of Sydney Medical School, Sydney, Australia.
Ophthalmic Plast Reconstr Surg. 2022;38(3):300-303. doi: 10.1097/IOP.0000000000002100. Epub 2021 Nov 22.
To examine the necessity for lateral osteotomy for intact removal of tumors within the orbital lobe of the lacrimal gland.
Patients who, between 1992 and 2020, were scheduled for intact excision of well-defined masses within the orbital lobe of the lacrimal gland were identified from an orbital database. A retrospective review of the clinical records was performed and details of the tumor size obtained from histopathological reports. The first patients in the series had lateral osteotomy, whereas later, there was a shift toward osteotomy-free tumor excision through a skin-crease incision. The latter approach required isolation of the gland's orbital lobe on an intact sheet of periosteum, an anterior "flip" of the mass (out of the orbit, past the orbital rim) "hinged" at the isthmus between the orbital and palpebral lobes, and finally a division of the isthmus to release the intact mass.
Clinical details were available for 100 patients (50 male), with 56 tumors removed using lateral osteotomy and 44 without. The mean age at surgery was 50.3 years with osteotomy (median, 51.8; range, 19-85 years) and 51.1 years without (median, 50.3; range, 11-81 years; P = 0.81). There were no postoperative complications in either group. Although the range of tumor volumes was similar in the two groups (1.6-15.0 ml with osteotomy; 0.9-15.1 ml without), the average volume was somewhat greater in those having osteotomy (mean, 6.4 ml) as compared with those without (mean, 4.6 ml; P = 0.0016). Inadvertent rupture of the tumor occurred once in each group, with tumors of similar small size.
In many cases, large masses within the orbital lobe of the lacrimal gland can be safely removed intact, using the described flip technique without the need for lateral wall osteotomy.
探讨为完整切除泪腺眶叶内肿瘤而进行外侧截骨术的必要性。
从眼眶数据库中识别出1992年至2020年间计划对泪腺眶叶内边界清晰的肿块进行完整切除的患者。对临床记录进行回顾性分析,并从组织病理学报告中获取肿瘤大小的详细信息。该系列中的首例患者接受了外侧截骨术,而后来则转向通过皮肤褶皱切口进行无截骨的肿瘤切除。后一种方法需要在完整的骨膜片上分离泪腺的眶叶,将肿块向前“翻转”(移出眼眶,越过眶缘),以眶叶和睑叶之间的峡部为“铰链”,最后切断峡部以完整取出肿块。
有100例患者(50例男性)的临床详细资料可供分析,其中56例肿瘤通过外侧截骨术切除,44例未行截骨术。行截骨术患者的手术平均年龄为50.3岁(中位数为51.8岁;范围为19 - 85岁),未行截骨术患者的手术平均年龄为51.1岁(中位数为50.3岁;范围为11 - 81岁;P = 0.81)。两组均无术后并发症。虽然两组肿瘤体积范围相似(截骨术组为1.6 - 15.0毫升;未行截骨术组为0.9 - 15.1毫升),但截骨术组的平均体积(平均6.4毫升)略大于未行截骨术组(平均4.6毫升;P = 0.0016)。每组各有1例肿瘤意外破裂,破裂肿瘤大小相似。
在许多情况下,使用所述的翻转技术,无需外侧壁截骨术即可安全完整地切除泪腺眶叶内的大肿块。